Clinical Trials for Eledon Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Eledon Pharmaceuticals

Clinical Trials (4)

NCT06972069
Tolerance Through Mixed Chimerism (Sip-Tego)
EARLY_PHASE1Recruiting
12 participants
Started: May 31, 2025 · Completed: Dec 31, 2030
5 conditions3 sponsors1 location
NCT06126380
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
PHASE2Enrolling by invitation
132 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor37 locations
NCT05983770
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
PHASE2Active, not recruiting
120 participants
Started: Aug 30, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor56 locations
NCT05027906
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
PHASE1/PHASE2Recruiting
48 participants
Started: Feb 18, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor9 locations